News & Events
Press Releases
-
Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases
November 07, 2019 -
Astellas Commits Nearly $13 Million to Fund Boston-area Start-Up Innovation in Cell and Gene Therapy
October 01, 2019 -
Pfizer Inc. Awards “Golden Tickets” to Neutrolis and Mediar Therapeutics
September 27, 2019 -
SmartPharm Therapeutics Appoints Fred Driscoll to Board of Directors
September 06, 2019 -
LabCentral Appoints Biotech Industry Luminary Dr. Susan Windham-Bannister to its Board of Directors
September 05, 2019 -
Novo Nordisk to award promising start-ups free space at Boston's premier, biotech-capable shared lab facility
August 15, 2019 -
Bristol Myers-Squibb LabCentral 'Golden Ticket' Submission
July 03, 2019 -
Pfizer Opens Call for Proposals for Start-ups to Apply for LabCentral Residency
June 27, 2019 -
LabCentral 2018 Impact Report: Resident Companies Raised the Equivalent of 40% of Early Life Sciences VC Funding in Massachusetts and 6% of U.S. Life Sciences IPOs
May 07, 2019 -
EnClear Therapies Announces Seed Funding and Senior R&D Appointment
March 14, 2019